P
The startup develops a computational platform that employs quantum physics, molecular simulation, and artificial intelligence to design therapeutics with specific target product profiles. By integrating high-performance computing and expertise in disease biology, the company accelerates the development of effective molecular therapies.
Boston, United States
Updated 2 months ago
Funding
$50M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a computational platform that employs quantum physics, molecular simulation, and artificial intelligence to design therapeutics with specific target product profiles. By integrating high-performance computing and expertise in disease biology, the company accelerates the development of effective molecular therapies.